GLOBAL HELMINTHIC INFESTATIONS THERAPEUTICS MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Jul 2022 101
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Helminthic Infestations Therapeutics
1.2 Classification of Helminthic Infestations Therapeutics by Type
1.2.1 Overview: Global Helminthic Infestations Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Type in 2021
1.2.3 Benzimidazole
1.2.4 Pyrantel
1.2.5 Piperazine Citrate
1.2.6 Others
1.3 Global Helminthic Infestations Therapeutics Market by Application
1.3.1 Overview: Global Helminthic Infestations Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Enterobius vermicularis
1.3.3 Taenia saginata
1.3.4 Ascaris lumbricoides
1.3.5 Trichuris trichiura
1.3.6 Others
1.4 Global Helminthic Infestations Therapeutics Market Size & Forecast
1.5 Global Helminthic Infestations Therapeutics Market Size and Forecast by Region
1.5.1 Global Helminthic Infestations Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Helminthic Infestations Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Helminthic Infestations Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Helminthic Infestations Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Helminthic Infestations Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Helminthic Infestations Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Helminthic Infestations Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Helminthic Infestations Therapeutics Market Drivers
1.6.2 Helminthic Infestations Therapeutics Market Restraints
1.6.3 Helminthic Infestations Therapeutics Trends Analysis
2 Company Profiles
2.1 Neural Analytics, Inc.
2.1.1 Neural Analytics, Inc. Details
2.1.2 Neural Analytics, Inc. Major Business
2.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Neural Analytics, Inc. Recent Developments and Future Plans
2.2 M3 Biotechnology, Inc.
2.2.1 M3 Biotechnology, Inc. Details
2.2.2 M3 Biotechnology, Inc. Major Business
2.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.2.4 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 M3 Biotechnology, Inc. Recent Developments and Future Plans
2.3 Cerevance
2.3.1 Cerevance Details
2.3.2 Cerevance Major Business
2.3.3 Cerevance Helminthic Infestations Therapeutics Product and Solutions
2.3.4 Cerevance Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Cerevance Recent Developments and Future Plans
2.4 Mitochon Pharmaceuticals, Inc.
2.4.1 Mitochon Pharmaceuticals, Inc. Details
2.4.2 Mitochon Pharmaceuticals, Inc. Major Business
2.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.4.4 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Mitochon Pharmaceuticals, Inc. Recent Developments and Future Plans
2.5 Peptilogics
2.5.1 Peptilogics Details
2.5.2 Peptilogics Major Business
2.5.3 Peptilogics Helminthic Infestations Therapeutics Product and Solutions
2.5.4 Peptilogics Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Peptilogics Recent Developments and Future Plans
2.6 Farmoquimica S/A
2.6.1 Farmoquimica S/A Details
2.6.2 Farmoquimica S/A Major Business
2.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Product and Solutions
2.6.4 Farmoquimica S/A Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Farmoquimica S/A Recent Developments and Future Plans
2.7 biOasis Technologies, Inc.
2.7.1 biOasis Technologies, Inc. Details
2.7.2 biOasis Technologies, Inc. Major Business
2.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.7.4 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 biOasis Technologies, Inc. Recent Developments and Future Plans
2.8 HCA Healthcare, Inc.
2.8.1 HCA Healthcare, Inc. Details
2.8.2 HCA Healthcare, Inc. Major Business
2.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.8.4 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 HCA Healthcare, Inc. Recent Developments and Future Plans
2.9 Alzeca Biosciences, Inc.
2.9.1 Alzeca Biosciences, Inc. Details
2.9.2 Alzeca Biosciences, Inc. Major Business
2.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.9.4 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Alzeca Biosciences, Inc. Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Product and Solutions
2.10.4 Johnson & Johnson Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Helminthic Infestations Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Helminthic Infestations Therapeutics Players Market Share in 2021
3.2.2 Top 10 Helminthic Infestations Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Helminthic Infestations Therapeutics Players Head Office, Products and Services Provided
3.4 Helminthic Infestations Therapeutics Mergers & Acquisitions
3.5 Helminthic Infestations Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Helminthic Infestations Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Helminthic Infestations Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2017-2022)
5.2 Global Helminthic Infestations Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Helminthic Infestations Therapeutics Revenue by Type (2017-2028)
6.2 North America Helminthic Infestations Therapeutics Revenue by Application (2017-2028)
6.3 North America Helminthic Infestations Therapeutics Market Size by Country
6.3.1 North America Helminthic Infestations Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Helminthic Infestations Therapeutics Revenue by Type (2017-2028)
7.2 Europe Helminthic Infestations Therapeutics Revenue by Application (2017-2028)
7.3 Europe Helminthic Infestations Therapeutics Market Size by Country
7.3.1 Europe Helminthic Infestations Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Helminthic Infestations Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue by Application (2017-2028)
8.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region
8.3.1 Asia-Pacific Helminthic Infestations Therapeutics Revenue by Region (2017-2028)
8.3.2 China Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Helminthic Infestations Therapeutics Revenue by Type (2017-2028)
9.2 South America Helminthic Infestations Therapeutics Revenue by Application (2017-2028)
9.3 South America Helminthic Infestations Therapeutics Market Size by Country
9.3.1 South America Helminthic Infestations Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Helminthic Infestations Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Helminthic Infestations Therapeutics Revenue by Application (2017-2028)
10.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country
10.3.1 Middle East & Africa Helminthic Infestations Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Helminthic Infestations Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Helminthic Infestations Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Helminthic Infestations Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Helminthic Infestations Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Helminthic Infestations Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. Neural Analytics, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Neural Analytics, Inc. Major Business
Table 8. Neural Analytics, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 9. Neural Analytics, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. M3 Biotechnology, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. M3 Biotechnology, Inc. Major Business
Table 12. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 13. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Cerevance Corporate Information, Head Office, and Major Competitors
Table 15. Cerevance Major Business
Table 16. Cerevance Helminthic Infestations Therapeutics Product and Solutions
Table 17. Cerevance Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Mitochon Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Mitochon Pharmaceuticals, Inc. Major Business
Table 20. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 21. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Peptilogics Corporate Information, Head Office, and Major Competitors
Table 23. Peptilogics Major Business
Table 24. Peptilogics Helminthic Infestations Therapeutics Product and Solutions
Table 25. Peptilogics Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Farmoquimica S/A Corporate Information, Head Office, and Major Competitors
Table 27. Farmoquimica S/A Major Business
Table 28. Farmoquimica S/A Helminthic Infestations Therapeutics Product and Solutions
Table 29. Farmoquimica S/A Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. biOasis Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. biOasis Technologies, Inc. Major Business
Table 32. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 33. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. HCA Healthcare, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. HCA Healthcare, Inc. Major Business
Table 36. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 37. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Alzeca Biosciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Alzeca Biosciences, Inc. Major Business
Table 40. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 41. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 43. Johnson & Johnson Major Business
Table 44. Johnson & Johnson Helminthic Infestations Therapeutics Product and Solutions
Table 45. Johnson & Johnson Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Helminthic Infestations Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Helminthic Infestations Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Helminthic Infestations Therapeutics Players Head Office, Products and Services Provided
Table 50. Helminthic Infestations Therapeutics Mergers & Acquisitions in the Past Five Years
Table 51. Helminthic Infestations Therapeutics New Entrants and Expansion Plans
Table 52. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 53. Global Helminthic Infestations Therapeutics Revenue Share by Type (2017-2022)
Table 54. Global Helminthic Infestations Therapeutics Revenue Forecast by Type (2023-2028)
Table 55. Global Helminthic Infestations Therapeutics Revenue by Application (2017-2022)
Table 56. Global Helminthic Infestations Therapeutics Revenue Forecast by Application (2023-2028)
Table 57. North America Helminthic Infestations Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Helminthic Infestations Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Helminthic Infestations Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Helminthic Infestations Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Helminthic Infestations Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Helminthic Infestations Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Helminthic Infestations Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Helminthic Infestations Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Helminthic Infestations Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Helminthic Infestations Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Helminthic Infestations Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Helminthic Infestations Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Helminthic Infestations Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Helminthic Infestations Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Helminthic Infestations Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Helminthic Infestations Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Helminthic Infestations Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Helminthic Infestations Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Helminthic Infestations Therapeutics Picture
Figure 2. Global Helminthic Infestations Therapeutics Revenue Market Share by Type in 2021
Figure 3. Benzimidazole
Figure 4. Pyrantel
Figure 5. Piperazine Citrate
Figure 6. Others
Figure 7. Helminthic Infestations Therapeutics Revenue Market Share by Application in 2021
Figure 8. Enterobius vermicularis Picture
Figure 9. Taenia saginata Picture
Figure 10. Ascaris lumbricoides Picture
Figure 11. Trichuris trichiura Picture
Figure 12. Others Picture
Figure 13. Global Helminthic Infestations Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Helminthic Infestations Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Helminthic Infestations Therapeutics Revenue Market Share by Region (2017-2028)
Figure 16. Global Helminthic Infestations Therapeutics Revenue Market Share by Region in 2021
Figure 17. North America Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Helminthic Infestations Therapeutics Market Drivers
Figure 23. Helminthic Infestations Therapeutics Market Restraints
Figure 24. Helminthic Infestations Therapeutics Market Trends
Figure 25. Neural Analytics, Inc. Recent Developments and Future Plans
Figure 26. M3 Biotechnology, Inc. Recent Developments and Future Plans
Figure 27. Cerevance Recent Developments and Future Plans
Figure 28. Mitochon Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 29. Peptilogics Recent Developments and Future Plans
Figure 30. Farmoquimica S/A Recent Developments and Future Plans
Figure 31. biOasis Technologies, Inc. Recent Developments and Future Plans
Figure 32. HCA Healthcare, Inc. Recent Developments and Future Plans
Figure 33. Alzeca Biosciences, Inc. Recent Developments and Future Plans
Figure 34. Johnson & Johnson Recent Developments and Future Plans
Figure 35. Global Helminthic Infestations Therapeutics Revenue Share by Players in 2021
Figure 36. Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Helminthic Infestations Therapeutics Revenue Market Share in 2021
Figure 38. Global Top 10 Players Helminthic Infestations Therapeutics Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Helminthic Infestations Therapeutics Revenue Share by Type in 2021
Figure 41. Global Helminthic Infestations Therapeutics Market Share Forecast by Type (2023-2028)
Figure 42. Global Helminthic Infestations Therapeutics Revenue Share by Application in 2021
Figure 43. Global Helminthic Infestations Therapeutics Market Share Forecast by Application (2023-2028)
Figure 44. North America Helminthic Infestations Therapeutics Sales Market Share by Type (2017-2028)
Figure 45. North America Helminthic Infestations Therapeutics Sales Market Share by Application (2017-2028)
Figure 46. North America Helminthic Infestations Therapeutics Revenue Market Share by Country (2017-2028)
Figure 47. United States Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Helminthic Infestations Therapeutics Sales Market Share by Type (2017-2028)
Figure 51. Europe Helminthic Infestations Therapeutics Sales Market Share by Application (2017-2028)
Figure 52. Europe Helminthic Infestations Therapeutics Revenue Market Share by Country (2017-2028)
Figure 53. Germany Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Helminthic Infestations Therapeutics Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Helminthic Infestations Therapeutics Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Helminthic Infestations Therapeutics Revenue Market Share by Region (2017-2028)
Figure 61. China Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Helminthic Infestations Therapeutics Sales Market Share by Type (2017-2028)
Figure 68. South America Helminthic Infestations Therapeutics Sales Market Share by Application (2017-2028)
Figure 69. South America Helminthic Infestations Therapeutics Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Helminthic Infestations Therapeutics Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Helminthic Infestations Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source

Table of Contents

Related reports :

(Sep 22)

This report studies the global Elderly Wheelchair production, demand, key manufacturers, and key regions. This report is a detailed a...

(Sep 22)

According to our (Global Info Research) latest study, the global Elderly Wheelchair market size was valued at USD million in 2021 and is for...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

Global Info Research

GLOBAL HELMINTHIC INFESTATIONS THERAPEUTICS MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy